Modulation of transmural repolarization

被引:42
作者
Antzelevitch, C [1 ]
机构
[1] Masonic Med Res Lab, Utica, NY 13501 USA
来源
COMMUNICATIVE CARDIAC CELL | 2005年 / 1047卷
关键词
Brugada syndrome; cardiac heterogeneity; electrocardiogram; long QT syndrome; M cell; short QT syndrome;
D O I
10.1196/annals.1341.028
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ventricular myocardium in larger mammals has been shown to be comprised of three distinct cell types: epicardial, M, and endocardial. Epicardial and M cell action potentials differ from endocardial cells with respect to the morphology of phase 1. These cells possess a prominent I-to mediated notch responsible for the "spike and dome" morphology of the epicardial and M cell response. M cells are distinguished from the other cell types in that they display a smaller I-Ks, but a larger late I-Na and INa-Ca. These ionic distinctions underlie the longer action potential duration (APD) and steeper APD-rate relationship of the M cell. Difference in the time course of repolarization of phase 1 and phase 3 are responsible for the inscription of the electrocardiographic J wave and T wave, respectively. These repolarization gradients are sensitively modulated by electrotonic communication among the three cells types, [K+](o), and the presence of drugs that either reduce or augment net repolarizing current. A reduction in net repolarizing current generally leads to a preferential prolongation of the M cell action potential, responsible for a prolongation of the QT interval and an increase in transmural dispersion of repolarization (TDR), which underlies the development of torsade de pointes arrhythmias. An increase in net repolarizing current can lead to a preferential abbreviation of the action potential of epicardium in the right ventricle (RV), and endocardium in the left ventricle (LV). These actions also lead to a TDR that manifests as the Brugada syndrome in RV and the short QT syndrome in LV.
引用
收藏
页码:314 / 323
页数:10
相关论文
共 76 条
[1]   Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with the long QT syndrome [J].
Ali, RHH ;
Zareba, W ;
Moss, AJ ;
Schwartz, PJ ;
Benhorin, J ;
Vincent, GM ;
Locati, EH ;
Priori, S ;
Napolitano, C ;
Towbin, JA ;
Hall, WJ ;
Robinson, JL ;
Andrews, ML ;
Zhang, L ;
Timothy, K ;
Medina, A .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (04) :457-461
[2]   Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties [J].
Antzelevitch, C ;
Belardinelli, L ;
Zygmunt, AC ;
Burashnikov, A ;
Di Diego, JM ;
Fish, JM ;
Cordeiro, JM ;
Thomas, G .
CIRCULATION, 2004, 110 (08) :904-910
[3]   Brugada syndrome - A decade of progress [J].
Antzelevitch, C ;
Brugada, P ;
Brugada, J ;
Brugada, R ;
Shimizu, W ;
Gussak, I ;
Riera, ARP .
CIRCULATION RESEARCH, 2002, 91 (12) :1114-1118
[4]   The Brugada syndrome: Ionic basis and arrhythmia mechanisms [J].
Antzelevitch, C .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2001, 12 (02) :268-272
[5]   Cellular mechanisms underlying the long QT syndrome [J].
Antzelevitch, C ;
Shimizu, W .
CURRENT OPINION IN CARDIOLOGY, 2002, 17 (01) :43-51
[6]   The M cell: Its contribution to the ECG and to normal and abnormal electrical function of the heart [J].
Antzelevitch, C ;
Shimizu, W ;
Yan, GX ;
Sicouri, S ;
Weissenburger, J ;
Nesterenko, VV ;
Burashnikov, A ;
Di Diego, J ;
Saffitz, J ;
Thomas, GP .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1999, 10 (08) :1124-1152
[7]  
ANTZELEVITCH C, 2002, HDB PHYSL HEART, P654
[8]  
Antzelevitch C., 2004, CARDIAC ELECTROPHYSI, P151
[9]   The controversial M cell [J].
Anyukhovsky, EP ;
Sosunov, EA ;
Gainullin, RZ ;
Rosen, MR .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1999, 10 (02) :244-260
[10]   The QT interval [J].
Bednar, MM ;
Harrigan, EP ;
Anziano, RJ ;
Camm, AJ ;
Ruskin, JN .
PROGRESS IN CARDIOVASCULAR DISEASES, 2001, 43 (05) :1-45